Because prostate cancer is driven by a gain of function in AR (androgen receptor) that is usually accompanied by DHT to drive expression of AR-induced genes [25,26], we classified significant SNPs into three groups (DHT-specific, ETH-specific, and shared between the two) based on the BAB score and treatment conditions. This evidence concerns the gene AR and prostate carcinoma.